Literature DB >> 3294392

Infection with Campylobacter pylori.

T Rokkas1, G E Sladen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3294392      PMCID: PMC5379373     

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN: 0035-8819


× No keyword cloud information.
  41 in total

1.  Immune response to Campylobacter pyloridis in patients with peptic ulceration.

Authors:  J Kaldor; W Tee; P McCarthy; J Watson; B Dwyer
Journal:  Lancet       Date:  1985-04-20       Impact factor: 79.321

2.  Urea hydrolysis in patients with Campylobacter pyloridis infection.

Authors:  B J Marshall; S R Langton
Journal:  Lancet       Date:  1986-04-26       Impact factor: 79.321

3.  Campylobacter pyloridis in children.

Authors:  S Cadranel; H Goossens; M De Boeck; A Malengreau; P Rodesch; J P Butzler
Journal:  Lancet       Date:  1986-03-29       Impact factor: 79.321

4.  Campylobacter pyloridis, urease, and gastric ulcers.

Authors:  S L Hazell; A Lee
Journal:  Lancet       Date:  1986-09-13       Impact factor: 79.321

5.  Rapid diagnosis of Campylobacter-associated gastritis.

Authors:  C A McNulty; R Wise
Journal:  Lancet       Date:  1985-06-22       Impact factor: 79.321

6.  Campylobacter pyloridis and gastritis in children.

Authors:  R Hill; J Pearman; P Worthy; V Caruso; S Goodwin; E Blincow
Journal:  Lancet       Date:  1986-02-15       Impact factor: 79.321

7.  Immune response to Campylobacter pyloridis.

Authors:  B J Rathbone; J I Wyatt; B W Worsley; L K Trejdosiewicz; R V Heatley; M S Losowsky
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

8.  Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers.

Authors:  F I Lee; I M Samloff; M Hardman
Journal:  Lancet       Date:  1985-06-08       Impact factor: 79.321

9.  Campylobacter pylori detected noninvasively by the 13C-urea breath test.

Authors:  D Y Graham; P D Klein; D J Evans; D G Evans; L C Alpert; A R Opekun; T W Boutton
Journal:  Lancet       Date:  1987-05-23       Impact factor: 79.321

10.  Isolation and characterization of Campylobacter pyloridis from gastric biopsies.

Authors:  D E Taylor; J A Hargreaves; L K Ng; R W Sherbaniuk; L D Jewell
Journal:  Am J Clin Pathol       Date:  1987-01       Impact factor: 2.493

View more
  5 in total

1.  Effectiveness of acid suppression in preventing gastroesophageal reflux disease (GERD) after successful treatment of Helicobacter pylori infection.

Authors:  T Rokkas; S D Ladas; C Liatsos; E Panagou; A Karameris; S A Raptis
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

2.  Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis.

Authors:  T Rokkas; S Ladas; C Liatsos; E Petridou; G Papatheodorou; S Theocharis; A Karameris; S Raptis
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

3.  Proliferating cell nuclear antigen (PCNA) immunostaining in Helicobacter pylori infection: impact of eradication.

Authors:  T Rokkas; C Liatsos; A Karameris; E Petridou; A Lazaris; D Antoniades; E Kalafatis
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

4.  Helicobacter pylori infection and gastric juice vitamin C levels. Impact of eradication.

Authors:  T Rokkas; G Papatheodorou; A Karameris; A Mavrogeorgis; N Kalogeropoulos; N Giannikos
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

5.  Association between gastrointestinal tract carriage of Candida, blood group O, and nonsecretion of blood group antigens in patients with peptic ulcer.

Authors:  A P Burford-Mason; J M Willoughby; J C Weber
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.